Covered recipient · General Payments record
AAVA KHATIWADA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,283.79
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.91 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.94 | 10 |
| Janssen Biotech, Inc. | $75.39 | 2 |
| Madrigal Pharmaceuticals | $58.13 | 2 |
| Ardelyx, Inc. | $30.67 | 2 |
| PFIZER INC. | $26.24 | 1 |
| Merck Sharp & Dohme Corporation | $18.30 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.93 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064188 | CMS |
| ABBVIE INC. | $20.16 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064190 | CMS |
| ABBVIE INC. | $13.20 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064192 | CMS |
| ABBVIE INC. | $17.54 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064194 | CMS |
| ABBVIE INC. | $16.12 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064196 | CMS |
| ABBVIE INC. | $20.00 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064198 | CMS |
| ABBVIE INC. | $25.59 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064200 | CMS |
| ABBVIE INC. | $19.30 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064202 | CMS |
| ABBVIE INC. | $33.89 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064204 | CMS |
| ABBVIE INC. | $15.21 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064206 | CMS |
| Ardelyx, Inc. | $15.88 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689134 | CMS |
| Ardelyx, Inc. | $14.79 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689136 | CMS |
| Janssen Biotech, Inc. | $39.18 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078581555 | CMS |
| Janssen Biotech, Inc. | $36.21 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078577724 | CMS |
| Madrigal Pharmaceuticals | $28.39 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144172819 | CMS |
| Madrigal Pharmaceuticals | $29.74 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144172821 | CMS |
| Merck Sharp & Dohme LLC | $18.30 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141885903 | CMS |
| PFIZER INC. | $26.24 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131521881 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.24 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137600673 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.